A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

NCT00490451 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: LY573636-sodium

Sponsor

Eli Lilly and Company